155 related articles for article (PubMed ID: 37353354)
21. Hepatosplenic gamma/delta T-cell lymphoma in bone marrow. A sinusoidal neoplasm with blastic cytologic features.
Vega F; Medeiros LJ; Bueso-Ramos C; Jones D; Lai R; Luthra R; Abruzzo LV
Am J Clin Pathol; 2001 Sep; 116(3):410-9. PubMed ID: 11554170
[TBL] [Abstract][Full Text] [Related]
22. Hepatosplenic αβ T-cell lymphoma with myelodysplastic syndrome.
Takaku T; Miyazawa K; Sashida G; Shoji N; Shimamoto T; Yamaguchi N; Ito Y; Nakamura S; Mukai K; Ohyashiki K
Int J Hematol; 2005 Aug; 82(2):143-7. PubMed ID: 16146847
[TBL] [Abstract][Full Text] [Related]
23. Hepatosplenic T-cell lymphoma and inflammatory bowel disease.
Thai A; Prindiville T
J Crohns Colitis; 2010 Nov; 4(5):511-22. PubMed ID: 21122554
[TBL] [Abstract][Full Text] [Related]
24. Gamma/delta T cell lymphoma.
Taguchi A; Miyazaki M; Sakuragi S; Shinohara K; Kamei T; Inoue Y
Intern Med; 2004 Feb; 43(2):120-5. PubMed ID: 15005254
[TBL] [Abstract][Full Text] [Related]
25. Hepatosplenic gammadelta T-cell lymphoma presenting with immune-mediated thrombocytopenia and hemolytic anemia (Evans' syndrome).
Motta G; Vianello F; Menin C; De Nicolo A; Agata S; Altavilla G; Pietrogrande F; Girolami A
Am J Hematol; 2002 Apr; 69(4):272-6. PubMed ID: 11921021
[TBL] [Abstract][Full Text] [Related]
26. Successful treatment of hepatosplenic T-cell lymphoma with fludarabine, high-dose cytarabine and subsequent unrelated umbilical cord blood transplantation.
Honda T; Yamaoka M; Terao YM; Hasegawa D; Kumamoto T; Takagi M; Yoshida K; Ogawa S; Goto H; Akiyama M
Int J Hematol; 2022 Jan; 115(1):140-145. PubMed ID: 34591292
[TBL] [Abstract][Full Text] [Related]
27. Intensive induction chemotherapy followed by early high-dose therapy and hematopoietic stem cell transplantation results in improved outcome for patients with hepatosplenic T-cell lymphoma: a single institution experience.
Voss MH; Lunning MA; Maragulia JC; Papadopoulos EB; Goldberg J; Zelenetz AD; Horwitz SM
Clin Lymphoma Myeloma Leuk; 2013 Feb; 13(1):8-14. PubMed ID: 23107915
[TBL] [Abstract][Full Text] [Related]
28. Malignant lymphoma without lymphadenopathy.
Kini U; Alexander B; Correa M
J Assoc Physicians India; 2008 May; 56():383-5. PubMed ID: 18700647
[TBL] [Abstract][Full Text] [Related]
29. Intensive Induction Therapy Compared With CHOP for Hepatosplenic T-cell Lymphoma.
Klebaner D; Koura D; Tzachanis D; Ball ED; Horwitz S; Goodman AM
Clin Lymphoma Myeloma Leuk; 2020 Jul; 20(7):431-437.e2. PubMed ID: 32284297
[TBL] [Abstract][Full Text] [Related]
30. Pancytopenia in a Young Male Patient With Inflammatory Bowel Disease.
Jansson-Knodell CL; Walker MJ; Fischer M
Gastroenterology; 2021 Apr; 160(5):1483-1485. PubMed ID: 32777287
[No Abstract] [Full Text] [Related]
31. Outcomes of Hepatosplenic T-Cell Lymphoma: The Mayo Clinic Experience.
Bojanini L; Jiang L; Tun AJ; Ayala E; Menke DM; Hoppe B; Kharfan-Dabaja MA; Tun HW; Alhaj Moustafa M
Clin Lymphoma Myeloma Leuk; 2021 Feb; 21(2):106-112.e1. PubMed ID: 33160933
[TBL] [Abstract][Full Text] [Related]
32. Hepatosplenic gammadelta T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients.
Belhadj K; Reyes F; Farcet JP; Tilly H; Bastard C; Angonin R; Deconinck E; Charlotte F; Leblond V; Labouyrie E; Lederlin P; Emile JF; Delmas-Marsalet B; Arnulf B; Zafrani ES; Gaulard P
Blood; 2003 Dec; 102(13):4261-9. PubMed ID: 12907441
[TBL] [Abstract][Full Text] [Related]
33. Persistent non-neoplastic gammadelta-T cells in cerebrospinal fluid of a patient with hepatosplenic (gammadelta) T cell lymphoma: a case report with 6 years of flow cytometry follow-up.
Jiang L; Abati AD; Wilson W; Stetler-Stevenson M; Yuan C
Int J Clin Exp Pathol; 2009 Oct; 3(1):110-6. PubMed ID: 19918335
[TBL] [Abstract][Full Text] [Related]
34. Hepatosplenic T Cell Lymphoma: Diagnostic Conundrum.
Chowdhury Z; Khonglah Y; Raphael V; Kalita P; Das U
Int J Hematol Oncol Stem Cell Res; 2022 Jan; 16(1):66-73. PubMed ID: 35975114
[TBL] [Abstract][Full Text] [Related]
35. A Case of Hepatosplentic T Cell Lymphoma - A Rare, Aggressive Tumor of the Young.
Cingam S; Patel S; Koshy N
J La State Med Soc; 2017; 169(2):49-50. PubMed ID: 28414669
[TBL] [Abstract][Full Text] [Related]
36. Effect of chidamide on treating hepatosplenic T-cell lymphoma: A case report.
Wang XT; Guo W; Sun M; Han W; Du ZH; Wang XX; Du BB; Bai O
World J Clin Cases; 2020 Jul; 8(14):3122-3129. PubMed ID: 32775395
[TBL] [Abstract][Full Text] [Related]
37. Hepatosplenic gamma/delta T-cell lymphoma with isochromosome 7q, translocation t(7;21), and tetrasomy 8 in a 9-year-old girl.
Rossbach HC; Chamizo W; Dumont DP; Barbosa JL; Sutcliffe MJ
J Pediatr Hematol Oncol; 2002 Feb; 24(2):154-7. PubMed ID: 11990705
[TBL] [Abstract][Full Text] [Related]
38. T-cell-rich B-cell lymphoma of the spleen presenting with severe hypersplenism.
Dincol G; Agan M; Dogan O; Diz-Kucukkaya R; Uslu B
Clin Lab Haematol; 2006 Dec; 28(6):419-22. PubMed ID: 17105497
[TBL] [Abstract][Full Text] [Related]
39. Case report: a common presentation of a rare disease-hepatosplenic T-cell lymphoma.
Munir J; Preston G; Polish R
Hawaii Med J; 2004 Nov; 63(11):341-3. PubMed ID: 15633661
[TBL] [Abstract][Full Text] [Related]
40. [Hepatosplenic gammadeltaT-cell lymphoma: a clinicopathological study].
Geng J; Zhu MG; Ding YQ; Han HX
Di Yi Jun Yi Da Xue Xue Bao; 2004 Jan; 24(1):88-90. PubMed ID: 14724108
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
